Incidence and survival of non-small cell lung cancer in Shanghai: a population-based cohort study
Open Access
Abstract
Objectives Large population-based studies on the incidence and outcome of non-small cell lung cancer (NSCLC) are lacking in mainland China. This study aimed to investigate the NSCLC incidence, demographic features and survival as well as factors affecting survival of patients with NSCLC in Shanghai. Design Prospective observational cohort study. Setting Baseline information was collected from Shanghai Health Information Network, which is based on the Health Information Systems from all the comprehensive hospitals and specialist hospitals qualified for cancer diagnosis in the Shanghai metropolitan area. Participants All NSCLC cases identified from the database between 2011 and 2013 were recruited (15 020 patients). Main results The crude and age-adjusted incidences of NSCLC were 54.20 per 100 000 people (55.90 per 100 000 for men, 52.39 per 100 000 for women) and 39.05 per 100 000 people (41.43 per 100 000 for men and 37.13 per 100 000 for women), respectively. The median survival time was 22.7 months (95% CI 21.8 to 24.2 months) with an overall 1-year survival rate of 71.8% (95% CI 69.8% to 73.8%). The 1-year survival rate was 96.5% (95% CI 94.0% to 98.6%) in patients with stage I NSCLC, 89.1% (95% CI 83.3% to 94.9%) in patients with stage II NSCLC, 78.8% (95% CI 74.1% to 83.5%) in patients with stage IIIa NSCLC and 58.9% (95% CI 56.1% to 61.7%) in patients with stage IIIb/IV NSCLC. Multivariate analysis showed surgical resection (HR=0.607, 95% CI 0.511 to 0.722) and chemotherapy (HR=0.838, 95% CI 0.709 to 0.991) significantly improved survival. Factors associated with poor survival included older age, male sex, larger tumour size, lymph node metastasis, distant metastasis and squamous cell carcinoma. Conclusions A higher incidence and better survival rates for patients with NSCLC were identified when compared with previously published studies, which may provide evidence on the incidence and survival of NSCLC in China.Keywords
This publication has 38 references indexed in Scilit:
- Incidence Trends of Lung Cancer by Immigration Status among Chinese AmericansCancer Epidemiology, Biomarkers & Prevention, 2015
- Epidemiology of lung cancer in ChinaThoracic Cancer, 2015
- Lung Cancer Treatment Disparities in China: A Question in Need of an AnswerThe Oncologist, 2014
- Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens.2012
- Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countriesThe Lancet, 2011
- Asian Ethnicity Is a Favorable Prognostic Factor for Overall Survival in Non-small Cell Lung Cancer (NSCLC) and Is Independent of Smoking StatusJournal of Thoracic Oncology, 2009
- Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Model for Assessing Population-Related PharmacogenomicsJournal of Clinical Oncology, 2009
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007
- Ethnic Differences in Response to Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsJournal of Clinical Oncology, 2006
- Time trends in cancer mortality in China: 1987–1999International Journal of Cancer, 2003